Tailor your communication towards your patients to accurately control their cardiovascular risk

According to the recent 2019 ESC/EAS Guidelines for the management of dyslipidaemias, the importance of atherosclerotic cardiovascular (CV) disease prevention remains undisputed and should be delivered:

  • at the general population level by promoting healthy lifestyle behavior
  • at the individual level by tackling unhealthy lifestyles and by reducing increased levels of causal CV risk factors, such as low-density lipoprotein cholesterol (LDL-C), non-high-density lipoprotein cholesterol (non-HDL-C)and/or blood pressure levels.1

Healthcare professionals (HCPs) need to tailor their communication to individual patients

Evaluating the CV risk on an individual basis can not only help support clinical decision-making in managing patients with dyslipidemia but is also a powerful tool to support HCPs’ communication with patients, for instance by helping patients to set individual goals.1,2

HCPs can help support this behavior change by showing their patients the consequences of poor lipid control, which is a direct consequence of non-medication adherence, or unhealthy lifestyle habits.1,2

This innovative CV risk calculator is an easy-to-use tool, based on the recent ESC/EAS guidelines which can be used with any patient, including those in a (very) high-risk category. It also provides HCPs with recommendations for both LDL-C and non-HDL-C targets, in line with ESC/EAS guidelines.1


  1. Mach F, Baigent C, Catapano AL et al. ESC Scientific Document Group, 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal 2020;41(1):111–188. Available at: https://doi.org/10.1093/eurheartj/ehz455. Last accessed March 2021.
  2. Michie S, Wood CE, Johnston M, Abraham C, Francis JJ, Hardeman W. Behaviour change techniques: the development and evaluation of a taxonomic method for reporting and describing behaviour change interventions (a suite of five studies involving consensus methods, randomised controlled trials and analysis of qualitative data). Health Technol Assess. 2015 Nov;19(99):1-188. doi: 10.3310/hta19990. PMID: 26616119; Last accessed March 2021